SS Innovations Reports Record Q1 2026 Revenue as Global Adoption of SSi Mantra Surgical Robotic System Accelerates

SS Innovations International Inc. (NASDAQ: SSII) reported record first-quarter 2026 financial results, with revenue surging 116.8% year over year to $11.1 million, driven by accelerating adoption of its SSi Mantra surgical robotic platform. The company's installed base reached 194 systems across 11 countries, and cumulative robotic procedures climbed to nearly 9,750 during the quarter. Gross profit rose to $5.3 million from $1.1 million a year earlier, reflecting improved operational efficiency and higher system utilization.

The company continued its international expansion, securing regulatory approvals in Sri Lanka, Kenya, Indonesia, and the Philippines during the quarter. These approvals broaden market access in emerging healthcare regions where demand for minimally invasive surgical technologies is growing. SS Innovations is also pursuing regulatory clearance in the United States and Europe, which represent significant long-term growth opportunities.

During the quarter, SS Innovations completed the world’s longest-distance robotic cardiac telesurgery, demonstrating the capabilities of its remote surgery platform. This achievement underscores the potential of telesurgery to expand access to specialized surgical care in underserved areas. As of June 22, 2026, the cumulative number of multi-specialty procedures performed with the SSi Mantra system reached 11,719, including 612 cardiac procedures, 175 telesurgeries, and 212 pediatric surgeries. Approximately 2,100 physicians have been trained on the system, which has been used for over 170 different procedure types.

The strong quarterly performance and expanding clinical evidence base position SS Innovations to capitalize on the growing global demand for robotic-assisted surgery. The company's focus on emerging markets and telesurgery capabilities differentiates it from competitors concentrated in developed regions. With a growing installed base and increasing procedure volumes, SS Innovations is building a foundation for sustained revenue growth and market share gains in the surgical robotics industry.